Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study

医学 结直肠癌 化疗 辅助化疗 佐剂 肿瘤科 内科学 癌症 乳腺癌
作者
Richard Gray,J. Barnwell,Christopher C. McConkey,Robert K. Hills,Norman S. Williams,Rachel Kerr
出处
期刊:The Lancet [Elsevier]
卷期号:370 (9604): 2020-2029 被引量:1357
标识
DOI:10.1016/s0140-6736(07)61866-2
摘要

Background The aim of the QUASAR trial was to determine the size and duration of any survival benefit from adjuvant chemotherapy for patients with colorectal cancer at low risk of recurrence, for whom the indication for such treatment is unclear. Methods After apparently curative resections of colon or rectal cancer, 3239 patients (2963 [91%] with stage II [node negative] disease, 2291 [71%] with colon cancer, median age 63 [IQR 56–68] years) enrolled between May, 1994, and December, 2003, from 150 centres in 19 countries were randomly assigned to receive chemotherapy with fluorouracil and folinic acid (n=1622) or to observation (with chemotherapy considered on recurrence; n=1617). Chemotherapy was delivered as six 5-day courses every 4 weeks or as 30 once-weekly courses of intravenous fluorouracil (370 mg/m2) with high-dose (175 mg) L-folinic acid or low-dose (25 mg) L-folinic acid. Until 1997, levamisole (12 courses of 450 mg over 3 days repeated every 2 weeks) or placebo was added. After 1997, patients who were assigned to receive chemotherapy were given fluorouracil and low-dose folinic acid only. The primary outcome was all-cause mortality. Analyses were done by intention to treat. This trial is registered with the International Clinical Trial Registry, number ISRCTN82375386. Findings At the time of analysis, 61 (3·8%) patients in the chemotherapy group and 50 (3·1%) in the observation group had missing follow-up. After a median follow-up of 5·5 (range 0–10·6) years, there were 311 deaths in the chemotherapy group and 370 in the observation group; the relative risk of death from any cause with chemotherapy versus observation alone was 0·82 (95% CI 0·70–0·95; p=0·008). There were 293 recurrences in the chemotherapy group and 359 in the observation group; the relative risk of recurrence with chemotherapy versus observation alone was 0·78 (0·67–0·91; p=0·001). Treatment efficacy did not differ significantly by tumour site, stage, sex, age, or chemotherapy schedule. Eight (0·5%) patients in the chemotherapy group and four (0·25%) in the observation group died from non-colorectal cancer causes within 30 weeks of randomisation; only one of these deaths was deemed to be possibly chemotherapy related. Interpretation Chemotherapy with fluorouracil and folinic acid could improve survival of patients with stage II colorectal cancer, although the absolute improvements are small: assuming 5-year mortality without chemotherapy is 20%, the relative risk of death seen here translates into an absolute improvement in survival of 3·6% (95% CI 1·0–6·0).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mgg发布了新的文献求助10
刚刚
九九发布了新的文献求助30
1秒前
EthanYeung发布了新的文献求助10
1秒前
嘤嘤怪发布了新的文献求助10
1秒前
得意凡人发布了新的文献求助10
2秒前
Kimi完成签到,获得积分10
3秒前
4秒前
4秒前
良辰应助坚定老九采纳,获得10
4秒前
4秒前
5秒前
阳佟半仙完成签到,获得积分10
5秒前
早起大王完成签到,获得积分20
5秒前
香蕉觅云应助科研通管家采纳,获得10
6秒前
6秒前
小二郎应助科研通管家采纳,获得10
6秒前
无花果应助科研通管家采纳,获得10
6秒前
共享精神应助科研通管家采纳,获得10
6秒前
大模型应助科研通管家采纳,获得30
6秒前
模糊中正应助科研通管家采纳,获得40
6秒前
17发布了新的文献求助20
7秒前
7秒前
xcnjixin完成签到,获得积分10
7秒前
呆呆发布了新的文献求助10
7秒前
aiZYD完成签到,获得积分10
8秒前
Orange应助阿旭采纳,获得10
8秒前
8秒前
8秒前
4149完成签到,获得积分10
9秒前
王静完成签到,获得积分20
10秒前
wjx发布了新的文献求助20
11秒前
Akim应助mgg采纳,获得10
11秒前
11秒前
wjx发布了新的文献求助20
11秒前
11秒前
wjx发布了新的文献求助10
11秒前
wjx发布了新的文献求助10
11秒前
vv发布了新的文献求助10
12秒前
12秒前
13秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3295273
求助须知:如何正确求助?哪些是违规求助? 2931212
关于积分的说明 8451305
捐赠科研通 2603798
什么是DOI,文献DOI怎么找? 1421447
科研通“疑难数据库(出版商)”最低求助积分说明 660854
邀请新用户注册赠送积分活动 643847